查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1566852

乙酰左旋肉碱 (ALC) 市场：按类型、分销管道分类：2024-2033 年全球机会分析和产业预测

Acetyl-L Carnitine (ALC) Market By Type (Capsules, Tablets, Others) , By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 211 Pages | 商品交期: 2-3个工作天内

价格
简介目录

乙酰左旋肉碱 (ALC) 市场

2023 年乙酰左旋肉碱 (ALC) 市值为 5,810 万美元，预计 2024 年至 2033 年复合年增长率为 5.3%，到 2033 年达到 9,750 万美元。

乙酰左旋肉碱 (ALC) 是一种在人体内由胺基酸左旋肉碱合成的天然化合物。 ALC 在细胞能量形成中发挥重要作用，因为它促进脂肪酸转移到粒线体，脂肪酸在粒线体中被氧化以产生能量。血浆中的酯酶将 ALC 降解为肉碱，用于脂肪酸传输。此外，ALC 也参与乙酰胆碱的产生，乙酰胆碱有助于记忆和认知功能。由于其抗氧化特性和对神经细胞健康的支持，ALC 对神经退化性疾病有益。

由于乙酰左旋肉碱（ALC）是补充品中的重要成分，因此人们对保健补充品的认识和摄入量的提高是乙酰左旋肉碱（ALC）市场的关键驱动因素。此外，随着全球人口结构向老年群体转变，对支持认知功能和缓解与老龄化相关的健康问题的药物的需求将激增，导致对 ALC 的需求增加。目前，运动员中 ALC 摄入趋势正在显现，这种化合物已被证明在高强度运动表现中能产生积极的效果。 ALC 的正面结果归因于其在维持体内线粒体乙酰辅酶 A/辅酶 A 比例方面的作用。

然而，在膳食食品中使用 ALC 有多项健康法规，遵守这些法规是一项挑战。这限制了乙酰左旋肉碱（ALC）市场的成长。例如，美国健康与营养检查调查（营养与食品学会的膳食食品标籤资料库）分析了膳食食品配方中各种成分的使用情况，并制定了严格的用量指南。对包括 ALC 在内的营养成分进行严格监管对于防止过量摄取的严重后果是必要的。据报导，过量摄取摄取 ALC 会导致双极性情感障碍患者出现高血压、高三酸甘油酯和精神病。

分部审查

乙酰左旋肉碱 (ALC) 市场按类型、分销管道和区域细分。按类型划分，市场分为胶囊、锭剂。依分销管道分为医院药房、药局和零售药房以及线上供应商。从区域来看，分析涵盖北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

按类型划分，锭剂领域是 2023 年的最大股东。

按分销管道划分，2023年药局和零售药局细分市场占据较高市场占有率。

按地区划分，预计到 2033 年，北美地区的收益将最高。

该报告可以定制。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 扩大公司简介列表
  • 历史市场资料
  • 主要参与企业的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第 4 章 乙酰左旋肉碱 (ALC) 市场：依类型

  • 市场概况
  • 胶囊
  • 锭剂
  • 其他的

第五章乙酰左旋肉碱（ALC）市场：依分销管道

  • 市场概况
  • 医院药房
  • 药局和零售药房
  • 线上提供者

第六章乙酰左旋肉碱（ALC）市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国乙酰左旋肉碱（ALC）市场
    • 加拿大乙酰左旋肉碱（ALC）市场
    • 墨西哥乙酰左旋肉碱（ALC）市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国乙酰左旋肉碱（ALC）市场
    • 法国乙酰左旋肉碱（ALC）市场
    • 英国乙酰左旋肉碱（ALC）市场
    • 义大利乙酰左旋肉碱（ALC）市场
    • 西班牙乙酰左旋肉碱（ALC）市场
    • 其他欧洲乙酰左旋肉碱 (ALC) 市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本乙酰左旋肉碱（ALC）市场
    • 中国乙酰左旋肉碱（ALC）市场
    • 印度乙酰左旋肉碱（ALC）市场
    • 澳洲乙酰左旋肉碱（ALC）市场
    • 韩国乙酰左旋肉碱（ALC）市场
    • 其他亚太地区乙酰左旋肉碱 (ALC) 市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西乙酰左旋肉碱（ALC）市场
    • 沙乌地阿拉伯乙酰左旋肉碱（ALC）市场
    • 南非乙酰左旋肉碱（ALC）市场
    • 其他拉丁美洲/中东/非洲乙酰左旋肉碱 (ALC) 市场

第七章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第八章 公司简介

  • Nature's Bounty
  • Swanson
  • Namedsport Srl
  • Intas Pharmaceuticals Ltd.
  • NutriJa Lifesciences
  • Chemkart
  • Foodchem International Corporation
  • SimplySupplements
  • GNC Holdings, LLC
  • Solaray
简介目录
Product Code: A108370

Acetyl-L Carnitine (ALC) Market

The acetyl-L carnitine (ALC) market was valued at $58.1 million in 2023 and is projected to reach $97.5 million by 2033, growing at a CAGR of 5.3% from 2024 to 2033.

Acetyl-L-carnitine (ALC) is a natural compound synthesized inside the human body from the amino acid L-carnitine. ALC plays an essential role in cellular energy formation as it facilitates the transfer of fatty acids into the mitochondria, where they are oxidized to produce energy. Plasma esterases break down ALC in the blood into carnitine, which is then utilized for the transmission of fatty acids. In addition, ALC contributes to memory and cognitive function as it is involved in acetylcholine production. The antioxidant properties and nerve cell health support make ALC beneficial in neurodegenerative conditions.

Increase in awareness and uptake of health supplements is a key driver of the acetyl-L carnitine (ALC) market as the compound is an essential element of the supplements. Furthermore, as the demographics shift toward old age groups globally, the demand for ALC is rising due to surge in the requirement for medications that support cognitive function and mitigate age-related health concerns. Currently, the trend of the uptake of ALC is emerging among athletes as the compound has been identified to deliver positive outcomes during high-intensity sports performances. The positive results by ALC are attributed to its role in maintaining the mitochondrial acetyl-CoA/CoA ratio inside the body.

However, the usage of ALC in health supplements is subject to several health regulations, compliance with which is a challenging task. This restrains the growth of the acetyl-L carnitine (ALC) market. For instance, the National Health and Nutrition Examination Survey, a dietary supplement label database, by the Academy of Nutrition and Dietetics in the U.S. has imposed stringent guidelines pertaining to usage quantities of different components present in the formulations of health supplements. Such rigorous regulations over dietary components, including ALC, are required to prevent the severe outcomes of overdose. Overdoses of ALC have been reported to cause high blood pressure, high triglycerides, and psychosis in individuals suffering from bipolar disorder.

Segment Review

The acetyl-L carnitine (ALC) market is segmented into type, distribution channel, and region. On the basis of type, the market is divided into capsules, tablets, and others. As per distribution channel, it is classified into hospital pharmacies, drug stores & retail pharmacies, and online providers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the tablets segment was the highest shareholder in 2023.

As per distribution channel, the drug stores & retail pharmacies segment accounted for a high market share in 2023.

Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players operating in the global acetyl-L carnitine (ALC) market include Nature's Bounty, Swanson, Namedsport S.r.l., Intas Pharmaceuticals Ltd., NutriJa Lifesciences, Chemkart, Foodchem International Corporation, SimplySupplements , GNC Holdings, LLC, and Solaray. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Capsules
  • Tablets
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Providers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Nature's Bounty
    • Swanson
    • Namedsport S.r.l.
    • Intas Pharmaceuticals Ltd.
    • NutriJa Lifesciences
    • Chemkart
    • Foodchem International Corporation
    • SimplySupplements
    • GNC Holdings, LLC
    • Solaray

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ACETYL-L CARNITINE (ALC) MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Capsules
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Tablets
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Others
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: ACETYL-L CARNITINE (ALC) MARKET, BY DISTRIBUTION CHANNEL

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Distribution Channel
  • 5.2. Hospital Pharmacies
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Drug Stores And Retail Pharmacies
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Online Providers
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ACETYL-L CARNITINE (ALC) MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Type
    • 6.2.3. Market Size and Forecast, By Distribution Channel
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Acetyl-L Carnitine (ALC) Market
      • 6.2.5.1. Market Size and Forecast, By Type
      • 6.2.5.2. Market Size and Forecast, By Distribution Channel
    • 6.2.6. Canada Acetyl-L Carnitine (ALC) Market
      • 6.2.6.1. Market Size and Forecast, By Type
      • 6.2.6.2. Market Size and Forecast, By Distribution Channel
    • 6.2.7. Mexico Acetyl-L Carnitine (ALC) Market
      • 6.2.7.1. Market Size and Forecast, By Type
      • 6.2.7.2. Market Size and Forecast, By Distribution Channel
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Type
    • 6.3.3. Market Size and Forecast, By Distribution Channel
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Acetyl-L Carnitine (ALC) Market
      • 6.3.5.1. Market Size and Forecast, By Type
      • 6.3.5.2. Market Size and Forecast, By Distribution Channel
    • 6.3.6. France Acetyl-L Carnitine (ALC) Market
      • 6.3.6.1. Market Size and Forecast, By Type
      • 6.3.6.2. Market Size and Forecast, By Distribution Channel
    • 6.3.7. UK Acetyl-L Carnitine (ALC) Market
      • 6.3.7.1. Market Size and Forecast, By Type
      • 6.3.7.2. Market Size and Forecast, By Distribution Channel
    • 6.3.8. Italy Acetyl-L Carnitine (ALC) Market
      • 6.3.8.1. Market Size and Forecast, By Type
      • 6.3.8.2. Market Size and Forecast, By Distribution Channel
    • 6.3.9. Spain Acetyl-L Carnitine (ALC) Market
      • 6.3.9.1. Market Size and Forecast, By Type
      • 6.3.9.2. Market Size and Forecast, By Distribution Channel
    • 6.3.10. Rest of Europe Acetyl-L Carnitine (ALC) Market
      • 6.3.10.1. Market Size and Forecast, By Type
      • 6.3.10.2. Market Size and Forecast, By Distribution Channel
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Type
    • 6.4.3. Market Size and Forecast, By Distribution Channel
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Acetyl-L Carnitine (ALC) Market
      • 6.4.5.1. Market Size and Forecast, By Type
      • 6.4.5.2. Market Size and Forecast, By Distribution Channel
    • 6.4.6. China Acetyl-L Carnitine (ALC) Market
      • 6.4.6.1. Market Size and Forecast, By Type
      • 6.4.6.2. Market Size and Forecast, By Distribution Channel
    • 6.4.7. India Acetyl-L Carnitine (ALC) Market
      • 6.4.7.1. Market Size and Forecast, By Type
      • 6.4.7.2. Market Size and Forecast, By Distribution Channel
    • 6.4.8. Australia Acetyl-L Carnitine (ALC) Market
      • 6.4.8.1. Market Size and Forecast, By Type
      • 6.4.8.2. Market Size and Forecast, By Distribution Channel
    • 6.4.9. South Korea Acetyl-L Carnitine (ALC) Market
      • 6.4.9.1. Market Size and Forecast, By Type
      • 6.4.9.2. Market Size and Forecast, By Distribution Channel
    • 6.4.10. Rest of Asia-Pacific Acetyl-L Carnitine (ALC) Market
      • 6.4.10.1. Market Size and Forecast, By Type
      • 6.4.10.2. Market Size and Forecast, By Distribution Channel
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Type
    • 6.5.3. Market Size and Forecast, By Distribution Channel
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Acetyl-L Carnitine (ALC) Market
      • 6.5.5.1. Market Size and Forecast, By Type
      • 6.5.5.2. Market Size and Forecast, By Distribution Channel
    • 6.5.6. Saudi Arabia Acetyl-L Carnitine (ALC) Market
      • 6.5.6.1. Market Size and Forecast, By Type
      • 6.5.6.2. Market Size and Forecast, By Distribution Channel
    • 6.5.7. South Africa Acetyl-L Carnitine (ALC) Market
      • 6.5.7.1. Market Size and Forecast, By Type
      • 6.5.7.2. Market Size and Forecast, By Distribution Channel
    • 6.5.8. Rest of LAMEA Acetyl-L Carnitine (ALC) Market
      • 6.5.8.1. Market Size and Forecast, By Type
      • 6.5.8.2. Market Size and Forecast, By Distribution Channel

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Nature's Bounty
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Swanson
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Namedsport S.r.l.
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Intas Pharmaceuticals Ltd.
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. NutriJa Lifesciences
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Chemkart
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Foodchem International Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. SimplySupplements
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. GNC Holdings, LLC
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Solaray
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments